Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03687086 · ClinicalTrials.gov registry record · NA
Sleep Without Insomnia or The Use of Chronic Hypnotics
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 188
- Enrollment target
NCT03687086 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 188 participants.
The verdict
NCT03687086, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
Study Summary
Sleeping medications, called hypnotics, are often prescribed for insomnia and are associated with adverse health outcomes in older adults. Response rates to hypnotic discontinuation programs are often inadequate, and many patients eventually resume use of hypnotics, suggesting that other mechanisms need to be targeted to achieve and sustain high rates of non-use. Current programs focus on the tapering of hypnotics and/or the treatment of insomnia symptoms. These programs employ strategies such as supervised gradual taper, cognitive behavioral therapy targeting hypnotic withdrawal, and/or cognitive behavioral therapy for insomnia. Evidence suggests that another mechanism involving "placebo" effects may be a viable target for achieving and sustaining higher discontinuation rates. Cognitive expectancies play a key role in producing placebo effects, which are characterized as real improvements in sleep arising from psychosocial aspects of treatment rather than drug effects alone. In this study, investigators are comparing two programs for discontinuing hypnotic medications-a program that addresses placebo effects associated with hypnotic use and a program that does not address these effects.
Interventions
- OTHER Program A
- OTHER Program B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2018-12-11 |
| Est. Completion | 2023-11-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03687086
The ClinicalTrials.gov registry entry for NCT03687086 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Program A is the first listed.
NCT03687086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03687086 about?
NCT03687086 is a clinical study titled "Sleep Without Insomnia or The Use of Chronic Hypnotics". Sleeping medications, called hypnotics, are often prescribed for insomnia and are associated with adverse health outcomes in older adults. Response rates to hypnotic discontinuation programs are often inadequate, and many patients eventually resume use of hypnotics, suggesting that other mechanisms ...
What is the current status of trial NCT03687086?
This trial is currently completed. It is a NA study. The enrollment target is 188 participants. The study started on 2018-12-11. Estimated completion is 2023-11-27.
What interventions are being tested in trial NCT03687086?
The interventions under investigation include: Program A (OTHER), Program B (OTHER).
Who is sponsoring clinical trial NCT03687086?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.